Evidence map›Paper›PMID 34658299›Full record

ArticleMolecular imaging and radionuclide therapy2021

Prognostic Prediction of BRCA Mutations by

Semra Özdemir, Fatma Sılan, Mehmet Yılmaz Akgün, Nilgün Aracı, İsmail Çırpan, Fulya Koç Öztürk, Öztürk Özdemir

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Relationship between Baseline [Tomography (Ann Arbor, Mich.) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Semra ÖzdemirÇanakkale Onsekiz Mart University Faculty of Medicine, Department of Nuclear Medicine, Çanakkale, TurkeyORCID 0000-0003-1302-9630
Fatma SılanÇanakkale Onsekiz Mart University Faculty of Medicine, Department of Medical Genetics, Çanakkale, TurkeyORCID 0000-0001-7191-2240
Mehmet Yılmaz AkgünÇanakkale Onsekiz Mart University Faculty of Medicine, Department of General Surgery, Çanakkale, TurkeyORCID 0000-0002-5631-6050
Nilgün AracıÇanakkale State Hospital, Clinic of Nuclear Medicine, Çanakkale, TurkeyORCID 0000-0002-3998-3943
İsmail ÇırpanÇanakkale State Hospital, Clinic of Pathology, Çanakkale, TurkeyORCID 0000-0001-7437-6631
Fulya Koç ÖztürkÇanakkale Onsekiz Mart University Faculty of Medicine, Department of Nuclear Medicine, Çanakkale, TurkeyORCID 0000-0003-1551-4998
Öztürk ÖzdemirÇanakkale Onsekiz Mart University Faculty of Medicine, Department of Medical Genetics, Çanakkale, TurkeyORCID 0000-0003-1057-3235
Çanakkale Onsekiz Mart Üniversitesi · TRCanakkale Onsekiz Mart Universitesi Tip Fakultesi Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to investigate the prognostic prediction of germline BRCA1 and BRCA2 mutations by comparing the maximum standardized uptake value (SUV Methods: Retrospective interdisciplinary laboratory results of 92 patients with BC who had germline BRCA1 or BRCA2 mutation profiles and underwent Results: In PET/CT performed for primary staging, patients with BRCA-positive BC had significantly higher SUV Conclusion: The results of this study showed a strong association between BRCA mutations and SUV

Indexed as

18F-FDG PET/CTBRCA1-2 mutationbreast cancerSUVmax

Identifiers

PMID34658299
PMCPMC8522522
OpenAlexW3206132176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.